Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules
Childhood cancer Death Rates Decline, Incidence Stable, NCI Says In Report
In The Courts: Lilly’s Claims Figured In Scripts Written To Coach Sales res, Court Documents Show
NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies
Researcher Falsified EMF Data, ORI Says
Trending Stories
- Narjust Duma named associate director of the Cancer Care Equity Program at DFCI, Harvard Medical School
- Robert Stone: City of Hope aims to transform cancer care nationally through new models, partnerships
- Biden commits to creating “ARPA-H” research body in visit to Ohio State
- Amy Reed, physician and patient who “moved mountains” to end widespread use of power morcellation, dies at 44
- The Cancer Letter gets a new website
You may have noticed that things are looking different around here - Abecma receives FDA approval for multiple myeloma
